Lawrence Biegelsen
Stock Analyst at Wells Fargo
(0.85)
# 3,642
Out of 5,182 analysts
58
Total ratings
40.54%
Success rate
-10.21%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Lawrence Biegelsen
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BDX Becton, Dickinson and Company | Maintains: Equal-Weight | $184 → $157 | $149.52 | +5.00% | 6 | Feb 10, 2026 | |
| PODD Insulet | Maintains: Overweight | $350 → $360 | $182.87 | +96.86% | 6 | Nov 7, 2025 | |
| ABT Abbott Laboratories | Maintains: Overweight | $142 → $146 | $93.86 | +55.55% | 9 | Oct 16, 2025 | |
| NPCE NeuroPace | Upgrades: Overweight | $16 → $20 | $16.89 | +18.41% | 7 | Mar 14, 2024 | |
| TNDM Tandem Diabetes Care | Maintains: Overweight | $166 → $82 | $18.63 | +340.15% | 5 | Aug 4, 2022 | |
| TFX Teleflex | Downgrades: Equal-Weight | $248 | $135.52 | +83.00% | 1 | Jul 29, 2022 | |
| ISRG Intuitive Surgical | Maintains: Overweight | $350 → $339 | $466.64 | -27.35% | 2 | Apr 22, 2022 | |
| REE REE Automotive | Initiates: Underweight | $1.5 | $0.57 | +163.16% | 1 | Mar 25, 2022 | |
| LUNG Pulmonx | Maintains: Equal-Weight | $55 → $27 | $1.23 | +2,095.12% | 3 | Feb 24, 2022 | |
| ZBH Zimmer Biomet Holdings | Maintains: Underweight | $124 → $111 | $82.80 | +34.06% | 2 | Feb 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $144 | $59.32 | +142.33% | 1 | Jan 19, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Equal-Weight | $56 | $119.63 | -53.19% | 4 | Jan 19, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $68 → $74 | $66.74 | +10.88% | 6 | Oct 29, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Equal-Weight | $77 | $82.28 | -6.82% | 3 | Apr 28, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $85 → $90 | $12.12 | +642.57% | 1 | Mar 5, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | n/a | $90.74 | - | 1 | Dec 12, 2019 |
Becton, Dickinson and Company
Feb 10, 2026
Maintains: Equal-Weight
Price Target: $184 → $157
Current: $149.52
Upside: +5.00%
Insulet
Nov 7, 2025
Maintains: Overweight
Price Target: $350 → $360
Current: $182.87
Upside: +96.86%
Abbott Laboratories
Oct 16, 2025
Maintains: Overweight
Price Target: $142 → $146
Current: $93.86
Upside: +55.55%
NeuroPace
Mar 14, 2024
Upgrades: Overweight
Price Target: $16 → $20
Current: $16.89
Upside: +18.41%
Tandem Diabetes Care
Aug 4, 2022
Maintains: Overweight
Price Target: $166 → $82
Current: $18.63
Upside: +340.15%
Teleflex
Jul 29, 2022
Downgrades: Equal-Weight
Price Target: $248
Current: $135.52
Upside: +83.00%
Intuitive Surgical
Apr 22, 2022
Maintains: Overweight
Price Target: $350 → $339
Current: $466.64
Upside: -27.35%
REE Automotive
Mar 25, 2022
Initiates: Underweight
Price Target: $1.5
Current: $0.57
Upside: +163.16%
Pulmonx
Feb 24, 2022
Maintains: Equal-Weight
Price Target: $55 → $27
Current: $1.23
Upside: +2,095.12%
Zimmer Biomet Holdings
Feb 8, 2022
Maintains: Underweight
Price Target: $124 → $111
Current: $82.80
Upside: +34.06%
Jan 19, 2022
Upgrades: Overweight
Price Target: $144
Current: $59.32
Upside: +142.33%
Jan 19, 2022
Upgrades: Equal-Weight
Price Target: $56
Current: $119.63
Upside: -53.19%
Oct 29, 2021
Maintains: Equal-Weight
Price Target: $68 → $74
Current: $66.74
Upside: +10.88%
Apr 28, 2020
Downgrades: Equal-Weight
Price Target: $77
Current: $82.28
Upside: -6.82%
Mar 5, 2020
Upgrades: Overweight
Price Target: $85 → $90
Current: $12.12
Upside: +642.57%
Dec 12, 2019
Upgrades: Overweight
Price Target: n/a
Current: $90.74
Upside: -